EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Characterization of First-Line Drug-Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis

Maryam Gul, Sajid Ali iD, Abdul Rehman iD, Muhammad Qasim, Roomana Ali iD, Jody E Phelan, Aiman Waheed iD, Sajjad Ahmad, Mubbashir Hussain iD, Susana Campino, Taane G Clark iD, Taj Ali Khan

Pathogens · 22.04.2026 · 15 (5) · 455

DOI: 10.3390/pathogens15050455 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, online erschienen am 22.04.2026. Verfasst von Maryam Gul und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Kohat University of Science and Technology, Kohat 26000, Khyber Pakhtunkhwa, Pakistan. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant, Mutation, Antitubercular Agents. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UKRI MRC, EPSRC, HEC-NRPU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Resistance to first-line anti-tuberculosis drugs in Mycobacterium tuberculosis represents a significant public health challenge, particularly in high-burden tuberculosis (TB) settings such as Pakistan, where multidrug-resistant (MDR) forms further complicate disease control efforts. Drug resistance is primarily associated with mutations in rpoB, inhA, katG, embA, embB, embC, and pncA. The emergence of novel, region-specific variants underscores the urgent need for integrating genomic surveillance into routine TB diagnostics and regional control programs. This study aimed to identify the spectrum of mutations contributing to first-line drug resistance in MDR-TB isolates from Khyber Pakhtunkhwa, Pakistan.

Methods

Whole-genome sequencing was performed on 16 clinical isolates (12 MDR and 4 drug-susceptible) to identify resistance-associated mutations in rpoB, inhA, katG, embA, embB, embC, and pncA. Detected variants were interpreted using the World Health Organization (WHO) mutation catalogue to determine their association with drug resistance. Phylogenetic relationships were inferred using the Bacterial and Viral Bioinformatics Resource Center (BV-BRC) platform.

Results

A total of 16 M. tuberculosis isolates were analyzed to evaluate resistance to first-line anti-tuberculosis drugs. In rpoB, 76 distinct variants were identified, including canonical mutations such as Ser450Leu and His445Arg, as well as a potentially novel substitution, Ser431Phe, predicted to confer high-level rifampicin resistance. The katG and inhA genes harbored 24 and 27 mutations, respectively, including well-characterized substitutions such as Ser315Thr and Ala114Glu, which are strongly associated with isoniazid resistance. Mutations in embA and embB were linked to ethambutol resistance, with several variants localized within conserved transmembrane domains critical for drug interaction. Phylogenetic analysis revealed substantial genetic diversity and evidence of local transmission among MDR-TB isolates.

Conclusions

This study suggests that the genetic landscape of drug resistance in M. tuberculosis is highly dynamic in endemic regions. The findings highlight the importance of integrating region-specific mutation profiles into molecular diagnostic frameworks to enhance early detection, guide individualized therapeutic interventions, and strengthen strategies aimed at controlling the transmission of MDR-TB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantMutationAntitubercular AgentsDrug Resistance, Multiple, BacterialHumansPhylogenyWhole Genome SequencingMicrobial Sensitivity TestsPakistanBacterial Proteins

Stichwörter der Autor:innen

MDR-TBMycobacterium tuberculosisdrug-resistant tuberculosisphylogenetic analysiswhole-genome sequencing

Substanzen

Antitubercular AgentsBacterial Proteins

Autor:innen und Institutionen

  • Department of Microbiology, Kohat University of Science and Technology, Kohat 26000, Khyber Pakhtunkhwa, Pakistan.
  • Provincial TB Control Program, Hayatabad Medical Complex, Peshawar 25000, Khyber Pakhtunkhwa, Pakistan.
  • Institute of Biotechnology and Microbiology, Bacha Khan University, Charsadda 24420, Khyber Pakhtunkhwa, Pakistan.
  • Atta ur Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), Islamabad 44000, Islamabad, Pakistan.
  • Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
  • Center of Biotechnology and Microbiology, University of Peshawar, Peshawar 25120, Khyber Pakhtunkhwa, Pakistan.

ORCID-Profile: Sajid Ali, Abdul Rehman, Roomana Ali, Aiman Waheed, Mubbashir Hussain, Taane G Clark

Förderung

  • UKRI MRC
  • EPSRC
  • HEC-NRPU

Zitieren

APA

Gul, M., Ali, S., Rehman, A., Qasim, M., Ali, R., Phelan, J. E., Waheed, A., Ahmad, S., Hussain, M., Campino, S., Clark, T. G., & Khan, T. A. (2026). Genetic Characterization of First-Line Drug-Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis. Pathogens, 15(5), 455. https://doi.org/10.3390/pathogens15050455

Vancouver

Gul M, Ali S, Rehman A, Qasim M, Ali R, Phelan JE, et al. Genetic Characterization of First-Line Drug-Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis. Pathogens. 2026;15(5):455. doi:10.3390/pathogens15050455

BibTeX
@article{Gul2026,
  author = {Gul, Maryam and Ali, Sajid and Rehman, Abdul and Qasim, Muhammad and Ali, Roomana and Phelan, Jody E and Waheed, Aiman and Ahmad, Sajjad and Hussain, Mubbashir and Campino, Susana and Clark, Taane G and Khan, Taj Ali},
  title = {Genetic Characterization of First-Line Drug-Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis},
  journal = {Pathogens},
  year = {2026},
  volume = {15},
  number = {5},
  pages = {455},
  doi = {10.3390/pathogens15050455}
}
Kostenlos starten →